Belongia EA, Levine MZ, Olaiya O, Gross FL, et al. Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018. Vaccine 2020 Mar 4. pii: S0264-410X(20)30278.
PMID: 32145994